|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017725,
umls-concept:C0018546,
umls-concept:C0030705,
umls-concept:C0042153,
umls-concept:C0087111,
umls-concept:C0205160,
umls-concept:C0205402,
umls-concept:C0228174,
umls-concept:C0392747,
umls-concept:C0443172,
umls-concept:C1457887
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1996-5-24
|
|
pubmed:abstractText |
The purpose of this report was to determine 1) the effects of chronic haloperidol treatment on cerebral metabolism in schizophrenic patients, 2) the relation between negative symptoms and haloperidol-induced regional changes in cerebral glucose utilization, and 3) the relation between metabolic change and clinical antipsychotic effect.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0002-953X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
153
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
346-54
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:8610821-Adult,
pubmed-meshheading:8610821-Amphetamines,
pubmed-meshheading:8610821-Brain,
pubmed-meshheading:8610821-Corpus Striatum,
pubmed-meshheading:8610821-Glucose,
pubmed-meshheading:8610821-Haloperidol,
pubmed-meshheading:8610821-Humans,
pubmed-meshheading:8610821-Male,
pubmed-meshheading:8610821-Psychiatric Status Rating Scales,
pubmed-meshheading:8610821-Receptors, Dopamine,
pubmed-meshheading:8610821-Schizophrenia,
pubmed-meshheading:8610821-Schizophrenic Psychology,
pubmed-meshheading:8610821-Tomography, Emission-Computed,
pubmed-meshheading:8610821-Tomography, X-Ray Computed
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Blunted change in cerebral glucose utilization after haloperidol treatment in schizophrenic patients with prominent negative symptoms.
|
|
pubmed:affiliation |
Psychiatry Service, New York VA Medical Center, 10010, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.
|
